Angiotensin Receptor Blockers : Current Status and Future ProspectsRAM, C. Venkata S.The American journal of medicine. 2008, Vol 121, Num 8, pp 656-663, issn 0002-9343, 8 p.Article

Angiotensin II-receptor blocker dosages : How high should we go?DÜSING, R.International journal of clinical practice (Esher). 2006, Vol 60, Num 2, pp 179-183, issn 1368-5031, 5 p.Article

Increased Capillary Branching Contributes to Angiotensin Type 1 Receptor Blocker (ARB)―Induced Regression of SclerosisSCRUGGS, Benjamin S; YIQIN ZUO; DONNERT, Ellen et al.The American journal of pathology. 2011, Vol 178, Num 4, pp 1891-1898, issn 0002-9440, 8 p.Article

Reduction of vascular noradrenaline sensitivity by AT₁ antagonists depends on functional sympathetic innervationRAASCH, Walter; DOMINIAK, Peter; ZIEGLER, Andreas et al.Hypertension (Dallas, Tex. 1979). 2004, Vol 44, Num 3, pp 346-351, issn 0194-911X, 6 p.Article

LES INHIBITEURS COMPETITIFS DE L'ANGIOTENSINE IICHAMONTIN B; SALVADOR M; GUITTARD J et al.1980; THERAPIE; ISSN 0040-5957; FRA; DA. 1980; VOL. 35; NO 5; PP. 637-640; BIBL. 18 REF.Article

Feasibility of treating prehypertension with an angiotensin-receptor blockerJULIUS, Stevo; NESBITT, Shawna D; SCHORK, M. Anthony et al.The New England journal of medicine. 2006, Vol 354, Num 16, pp 1685-1697, issn 0028-4793, 13 p.Article

Angiotensin receptor antagonists : a new class of antihypertensive drugGIBBS, C. R; FERNER, R. E; BEEVERS, D. G et al.Journal of clinical pharmacy and therapeutics (Print). 1996, Vol 21, Num 3, pp 127-130, issn 0269-4727Article

2nd international forum on angiotensin II receptor antagonism (Monte-Carlo, January 24-26 2001, abstracts)International forum on angiotensin II receptor antagonism. 2001, 44 p.Conference Proceedings

Twisting arms to angiotensin receptor blockers/antagonists: the turn of cancerVOLPE, Massimo; AZIZI, Michel; JAN DANSER, A. H et al.European heart journal. 2011, Vol 32, Num 1, pp 19-22, issn 0195-668X, 4 p.Article

Angiotensin II can induce and potentiate shape change in human platelets : effect of losartanJAGROOP, I. A; MIKHAILIDIS, D. P.Journal of human hypertension. 2000, Vol 14, Num 9, pp 581-585, issn 0950-9240Article

A cyclic angiotensin antagonist: [1,8-cysteine]angiotensin IIMATSOUKAS, J. M; SCANLON, M. N; MOORE, G. J et al.Journal of medicinal chemistry (Print). 1984, Vol 27, Num 3, pp 404-406, issn 0022-2623Article

Uptake of angiotensin II receptor blockers in the treatment of hypertensionGREVING, Jacoba P; DENIG, Petra; VAN DER VEEN, Willem Jan et al.European journal of clinical pharmacology. 2005, Vol 61, Num 5-6, pp 461-466, issn 0031-6970, 6 p.Article

High-Affinity Interaction of Sartans with H⁺/Peptide TransportersKNÜTTER, Ilka; KOTTRA, Gabor; FISCHER, Wiebke et al.Drug metabolism and disposition. 2009, Vol 37, Num 1, pp 143-149, issn 0090-9556, 7 p.Article

Trial of preventing hypertension: Design and 2-year progress reportJULIUS, Stevo; NESBITT, Shawna; EGAN, Brent et al.Hypertension (Dallas, Tex. 1979). 2004, Vol 44, Num 2, pp 125-126, issn 0194-911X, 8 p.Article

INFLUENCE OF PROSTAGLANDIN SYNTHESIS INHIBITORS ON PULMONARY VASODILATORY EFFECTS OF HYDRALAZINE IN DOGS WITH HYPOXIC PULMONARY VASOCONSTRICTIONRUBIN LJ; LAZAR JD.1981; J. CLIN. INVEST.; ISSN 0021-9738; USA; DA. 1981; VOL. 67; NO 1; PP. 193-200; BIBL. 41 REF.Article

HEMODYNAMICS OF A NEW ANGIOTENSIN ANTAGONIST, (SAR¹, THR⁸) A II, IN HYPERTENSIVE MANCODY RJ JR; TARAZI RC; FOUAD FM et al.1980; CIRCULATION; USA; DA. 1980; VOL. 61; NO 2; PP. 338-344; BIBL. 29 REF.Article

TEST A LA SARALASINE: INTERET DANS LE TRAITEMENT DES HYPERTENSIONS SEVERESBONNET F; CORVOL P; THIBONNIER M et al.1980; NOUV. PRESSE MED.; ISSN 0301-1518; FRA; DA. 1980; VOL. 9; NO 41; PP. 3075-3078; ABS. ENG; BIBL. 21 REF.Article

IMPROVEMENT IN ARTERIAL OXYGENATION BY SARALASIN INFUSION IN MANSAKTI MOOKHERJEE; OBEID AI; KUMAR ASHUTOSH et al.1979; CHEST; USA; DA. 1979; VOL. 75; NO 4; PP. 492-494; BIBL. 15 REF.Article

SYSTEMIC HEMODYNAMICS AND HORMONAL RESPONSES DURING ANGIOTENSIN II BLOCKADE WITH SARALASINROOS JC; GEYSKES GG; BOER P et al.1981; J. CARDIOVASC. PHARMACOL.; ISSN 0160-2446; USA; DA. 1981; VOL. 3; NO 5; PP. 1106-1115; BIBL. 28 REF.Article

THE INFLUENCE OF SARALA ANGIOTENSIN II (SARALASIN) ON PLASMA ALDOSTERONE IN HYPERTENSIVE PATIENTSDONKER AJM; VAN HOOGDALEM P; PRATT JJ et al.1979; ACTA MED. SCAND.; SWE; DA. 1979; VOL. 205; NO 3; PP. 207-212; BIBL. 21 REF.Article

INHIBITION OF THE RENIN-ANGIOTENSIN SYSTEM. A NEW APPROACH TO THE THERAPY OF HYPERTENSIONONDETTI MA; CUSHMAN DW.1981; J. MED. CHEM.; ISSN 0022-2623; USA; DA. 1981; VOL. 24; NO 4; PP. 355-361; BIBL. 61 REF.Article

ORGAN SELECTIVE ANGIOTENSIN ANTAGONISTS: SARCOSYL¹-CYSTEINYL (S-METHYL)⁸-ANGIOTENSIN IFREER RJ; SUTHERLAND JC JR; DAY AR et al.1980; EUROP. J. PHARMACOL.; NLD; DA. 1980; VOL. 65; NO 4; PP. 349-354; BIBL. 18 REF.Article

SARALASINA ED IPERTENSIONE ARTERIOSA A BASSA RENINEMIA = SARALASINE ET HYPERTENSION ARTERIELLE AVEC RENINEMIE BASSEFRISINA N; BUEMI M; LASCO A et al.1980; BOLL. SOC. ITAL. BIOL. SPER.; ITA; DA. 1980; VOL. 56; NO 13; PP. 1367-1373; ABS. ENG; BIBL. 14 REF.Article

Angiotensin receptor antagonists and increased risk of cancer. Further evidence againstMANCIA, Giuseppe.Journal of hypertension. 2011, Vol 29, Num 4, pp 653-654, issn 0263-6352, 2 p.Article

Rationale and design of a trial on the effect of angiotensin II receptor blockers on the function of the systemic right ventricleVAN DER BOM, Teun; WINTER, Michiel M; MULDER, Barbara J. M et al.The American heart journal. 2010, Vol 160, Num 5, pp 812-818, issn 0002-8703, 7 p.Article